**Abstract**

Object: Selective serotonin reuptake inhibitors (SSRI) are well-established first-line pharmacological treatments for obsessive-compulsive disorder (OCD), and serotonin transporter (5-HTT) may be the target of antidepressants and involved in the pathophysiology of OCD. In this study, we determined mRNA expression levels of the 5-HTT gene in the peripheral blood leukocytes of patients with OCD and control subjects (n = 53, each). Methods: Total RNA was extracted from the peripheral leukocytes of whole blood samples using the PAX gene Blood RNA kit. Real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis was performed with the ABI 7500 Fast Real-Time System. Expression differences between OCD patients and controls were tested using Student's t-test. All subjects signed written, informed consent forms that were approved by the institutional ethics committees of the University of Tokushima Graduate School. Results: The 5-HTT mRNA levels in patients were significantly higher than in healthy controls (P = 1.77 × 10^--5^). Conclusion: Our result may suggest that the elevated mRNA levels of 5-HTT might be implicated in the pathophysiology of OCD.
